Interestingly, in addition to the strong advantage of using the oral route, this approach is at least as efficient as the current marketed drug as a comparison and could even be more potent for improving oral glucose tolerance, insulin resistance and hepatic steatosis. The gene discussed is INS; the disease is fatty liver disease.